Insider · CIK 0001640073

Edwards Martin

Reports to the SEC for 6 companies · LONDON, X0

sec.gov

Transactions

Companies

Filings

CIK

0001640073

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2025-10-07	VRNAVerona Pharma plcD Disposition to Issuer	Director	DDisposition to Issuer	−72K sh	—	—	0
2025-10-07	VRNAVerona Pharma plc · Share Options (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−64K sh	—	—	0
2025-10-07	VRNAVerona Pharma plc · Share Options (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−240K sh	—	—	0
2025-10-07	VRNAVerona Pharma plc · Share Options (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−96K sh	—	—	0
2025-10-07	VRNAVerona Pharma plc · Share Options (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−200K sh	—	—	0
2025-10-07	VRNAVerona Pharma plcD Disposition to Issuer	Director	DDisposition to Issuer	−158K sh	—	—	0
2025-10-07	VRNAVerona Pharma plcM Exercise/Conversion	Director	MExercise/Conversion	+72K sh	—	—	72,000
2025-10-07	VRNAVerona Pharma plc · Restricted Share UnitM Exercise/Conversion	Director	MExercise/Conversion	−72K sh	—	—	0
2025-08-01	VRNAVerona Pharma plcM Exercise/Conversion	Director	MExercise/Conversion	+24K sh	—	—	168,800
2025-08-01	VRNAVerona Pharma plc · Restricted Stock UnitsM Exercise/Conversion	Director	MExercise/Conversion	−24K sh	—	—	72,000
2025-08-01	VRNAVerona Pharma plcS Sale	Director	SSale	−10.8K sh	$13.14	−$142K	157,992
2025-04-25	VRNAVerona Pharma plc · Restricted Share UnitsA Award	Director	AAward	+96K sh	—	—	96,000
2024-08-16	Morphic Holding, Inc.Stock Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−9,996 sh	—	—	0
2024-08-16	Morphic Holding, Inc.Stock Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−24K sh	—	—	0
2024-08-16	Morphic Holding, Inc.D Disposition to Issuer	Director	DDisposition to Issuer	−2,376 sh	—	—	0
2024-08-16	Morphic Holding, Inc.Stock Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−12.5K sh	—	—	0
2024-08-16	Morphic Holding, Inc.Stock Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−17.6K sh	—	—	0
2024-08-16	Morphic Holding, Inc.Stock Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−23.2K sh	—	—	0
2024-06-18	Inozyme Pharma, Inc.Stock Option (right to buy)A Award	Director	AAward	+28K sh	—	—	28,000
2024-06-04	Morphic Holding, Inc.Common StockA Award	Director	AAward	+23.2K sh	—	—	23,168
2024-04-29	VRNAVerona Pharma plc · Share Options (Right to Buy)A Award	Director	AAward	+240K sh	—	—	240,000
2023-11-20	VRNAVerona Pharma plcP Purchase	Director	PPurchase	+33.7K sh	$1.84	+$62K	144,800
2023-11-13	Morphic Holding, Inc.P Purchase	Director	PPurchase	+2,376 sh	$20.54	+$48.8K	2,376
2023-09-26	REATA PHARMACEUTICALS INCStock Option (right to buy)D Disposition to Issuer	Director	DDisposition to Issuer	−169 sh	—	—	0
2023-09-26	REATA PHARMACEUTICALS INCD Disposition to Issuer	Director	DDisposition to Issuer	−6,116 sh	—	—	0
2023-09-26	REATA PHARMACEUTICALS INCStock Option (right to buy)D Disposition to Issuer	Director	DDisposition to Issuer	−10K sh	—	—	0
2023-09-26	REATA PHARMACEUTICALS INCStock Option (right to buy)D Disposition to Issuer	Director	DDisposition to Issuer	−6,300 sh	—	—	0
2023-09-26	REATA PHARMACEUTICALS INCStock Option (right to buy)D Disposition to Issuer	Director	DDisposition to Issuer	−5,000 sh	—	—	0
2023-09-26	REATA PHARMACEUTICALS INCStock Option (right to buy)D Disposition to Issuer	Director	DDisposition to Issuer	−99 sh	—	—	0
2023-09-26	REATA PHARMACEUTICALS INCStock Option (right to buy)D Disposition to Issuer	Director	DDisposition to Issuer	−520 sh	—	—	0
2023-09-26	REATA PHARMACEUTICALS INCStock Option (right to buy)D Disposition to Issuer	Director	DDisposition to Issuer	−5,620 sh	—	—	0
2023-09-26	REATA PHARMACEUTICALS INCStock Option (right to buy)D Disposition to Issuer	Director	DDisposition to Issuer	−2,137 sh	—	—	0
2023-06-13	Inozyme Pharma, Inc.Stock Option (right to buy)A Award	Director	AAward	+16K sh	—	—	16,000
2023-06-07	REATA PHARMACEUTICALS INCA Award	Director	AAward	+1,682 sh	$93.61	+$157K	6,116
2023-06-07	REATA PHARMACEUTICALS INCStock Option (right-to-buy)A Award	Director	AAward	+169 sh	$73.68	+$12.5K	169
2023-06-07	REATA PHARMACEUTICALS INCStock Option (right-to-buy)A Award	Director	AAward	+2,137 sh	—	—	2,137
2023-06-07	REATA PHARMACEUTICALS INCA Award	Director	AAward	+133 sh	$93.61	+$12.5K	4,434
2023-06-01	Morphic Holding, Inc.Director Stock Option (Right to Buy)A Award	Director	AAward	+12.5K sh	—	—	12,535
2023-04-28	VRNAVerona Pharma plc · Share Options (Right to Buy)A Award	Director	AAward	+96K sh	—	—	96,000
2022-06-10	Inozyme Pharma, Inc.Stock Option (right to buy)A Award	Director	AAward	+9,367 sh	—	—	9,367
2022-06-08	REATA PHARMACEUTICALS INCStock Option (right-to-buy)A Award	Director	AAward	+520 sh	$24.02	+$12.5K	520
2022-06-08	REATA PHARMACEUTICALS INCA Award	Director	AAward	+359 sh	$34.76	+$12.5K	418
2022-06-08	REATA PHARMACEUTICALS INCA Award	Director	AAward	+3,883 sh	$34.76	+$135K	4,301
2022-06-08	REATA PHARMACEUTICALS INCStock Option (right-to-buy)A Award	Director	AAward	+5,620 sh	—	—	5,620
2022-06-08	Morphic Holding, Inc.Director Stock Option (Right to Buy)A Award	Director	AAward	+17.6K sh	—	—	17,550
2022-04-28	VRNAVerona Pharma plc · Share Options (Right to Buy)A Award	Director	AAward	+200K sh	—	—	200,000
2022-01-03	REATA PHARMACEUTICALS INCStock Option (right to buy)A Award	Director	AAward	+99 sh	$16.14	+$1,597.86	99
2022-01-03	REATA PHARMACEUTICALS INCA Award	Director	AAward	+59 sh	$27.32	+$1,611.88	59
2021-09-30	KalVista Pharmaceuticals, Inc.Director Stock Option (Right to Buy)A Award	Director	AAward	+10K sh	—	—	10,000
2021-08-09	VRNAVerona Pharma plc · Share Options (Right to Buy)A Award	Director	AAward	+64K sh	—	—	64,000

Recent filings

Accepted (ET)
Oct 84
Edwards Martin0001104659-25-097948
SEC(opens sec.gov)
Aug 54
Edwards Martin0001104659-25-074386
SEC(opens sec.gov)
Apr 294
Edwards Martin0001104659-25-041397
SEC(opens sec.gov)
Aug 214
Edwards Martin0001415889-24-021823
SEC(opens sec.gov)
Jun 204
Edwards Martin0000950170-24-075572
SEC(opens sec.gov)
Jun 54
Edwards Martin0001415889-24-015691
SEC(opens sec.gov)

Companies

Address

3 MORE LONDON RIVERSIDE

LONDON, X0, SE1 2RE